MedEdicus Podcasts – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

MedEdicus Podcasts

MedEdicus

Science

Frequency: 1 episode/62d. Total Eps: 13

MedEdicus is an accredited, independent, leading developer of continuing medical education and disease awareness programs. We providee quality continuing education to health care providers and other members of the patient care team around the globe. Each of our learning opportunities offers a case-based approach to make the experience clinically relevant.MedEdicus is accredited by the Accreditation Council of Continuing Medical Education (ACCME) to provide continuing medical education for physicians. We comply with all policies and guidelines of the US Food and Drug Administration, Office of Inspector General Guidance, and Pharmaceutical Research and Manufacturers of America Code.

Read moreCollapse

Site

RSS

Apple

Data updated on 04/07/2026

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

🇨🇦 Canada - Life Sciences
26/03/2025
#85
🇨🇦 Canada - Life Sciences
25/03/2025
#74
🇨🇦 Canada - Life Sciences
24/03/2025
#70
🇨🇦 Canada - Life Sciences
23/03/2025
#66

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://courses.mededicus.com/content/person-centered-care-approaches-treatment-patients-neuropsychiatric-manifestations-0#group-tabs-node-course-default1
2 shares
https://courses.mededicus.com/content/rtt-syndrome-update-evolving-management-strategies-cmece-podcast
2 shares
https://courses.mededicus.com/content/discussing-evaporative-dry-eye-incorporating-new-treatments-practice-cmece-podcast
2 shares

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 38%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

(CME Podcast) Improving Outcomes in Patients With Geographic Atrophy: Cases in Clinical Practice - Part 1

Wednesday, March 12, 2025 • Duration 29:48

Geographic atrophy is a growing healthcare concern for retina specialists caring for an aging population. In the first part of this podcast series titled, Improving Outcomes in Patients with Geographic Atrophy, our experts, Dr. Arshad Khanani and Dr. Lejla Vajzovic, will educate listeners on the disease epidemiology, pathophysiology, and relevant clinical features of GA on imaging. The discussion will include didactics presented by our experts and real-world case studies.

Read moreCollapse

Continuous Drug Delivery: Advancements in nAMD and DME (CME Podcast)

Wednesday, March 12, 2025 • Duration 51:47

This program provides retina specialists and other ophthalmologists caring for patients with neovascular AMD and DME with a comprehensive overview of sustained-release therapies for retinal diseases. Participants will appraise the latest clinical data on the safety and efficacy of sustained delivery platforms, including the Port Delivery System (PDS) with ranibizumab, and emerging options like tyrosine kinase inhibitors and gene therapies. The program will detail the technical considerations for optimizing the safety and efficacy of sustained delivery, with a specific focus on the PDS surgical implantation and refill-exchange procedures. Through case-based discussions, learners will evaluate patient-specific characteristics to determine the appropriate implementation of sustained delivery platforms, considering factors such as treatment history, ocular comorbidities, and individual patient needs to select optimal treatment approaches for neovascular AMD and DME.

Target Audience:

Retina specialists and other ophthalmologists caring for patients with neovascular AMD and DME.

Learning Objectives:

Appraise the latest data regarding the safety and efficacy of sustained delivery platforms for retinal diseases
Identify technical considerations to optimize the safety and efficacy of sustained delivery therapies for retinal diseases
Evaluate patient-specific characteristics when considering implementation of sustained delivery platforms for retinal diseases

Read moreCollapse

(CME Podcast) Improving Outcomes in Patients with Geographic Atrophy: Cases in Clinical Practice - Part 2

Wednesday, March 12, 2025 • Duration 28:25

In part 2 of our podcast series on geographic atrophy, Dr. Lejla Vajzovic and Dr. Arshad Khanani will do a deep dive into current treatment options to optimize patient outcomes. Listeners will be enabled to develop treatment plans for patients with geographic atrophy through a review of clinical study data, case scenarios, and real-world cases. This comprehensive session will empower listeners to confidently assess and manage geographic atrophy in their practice.

Read moreCollapse

Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Monitoring (CE/CME Podcast) - Part 3

Wednesday, March 12, 2025 • Duration 24:36

This podcast, Part 3 of a 3-part series on thyroid eye disease (TED), examines the multidisciplinary management of TED with a focus on teprotumumab-associated adverse effects. Through expert discussions and case-based examples, listeners will learn best practices for managing hyperglycemia, hearing changes, and other potential complications. The session outlines the essential role of primary eye care professionals in comanaging TED, from early recognition to educating patients and coordinating care with specialists. Clinicians will be equipped to apply collaborative strategies to optimize outcomes for TED patients.

Read moreCollapse

Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Treatment (CE/CME Podcast) - Part 2

Wednesday, March 12, 2025 • Duration 27:05

This podcast, Part 2 of a 3-part series on thyroid eye disease (TED), provides an in-depth discussion of treatment strategies, focusing on current medical and surgical options as well as emerging therapies. Faculty review clinical data on teprotumumab, the only FDA-approved agent for TED. Listeners will also be introduced to clinical data on treatments including glucocorticoids, orbital radiation, rituximab, and tocilizumab and learn how to select appropriate therapies across a spectrum of disease activity and duration.

Read moreCollapse

Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Diagnosis (CME/CE Podcast) - Part 1

Wednesday, March 12, 2025 • Duration 26:34

This podcast, Part 1 of a 3-part series on thyroid eye disease (TED), explores the clinical features of both active and chronic disease, providing a foundation for understanding how to effectively diagnose and manage this condition. Through expert discussions, the faculty review key diagnostic tools and clinical signs, offering insights into the spectrum of TED activity and duration. Listeners will also gain guidance on selecting appropriate treatments tailored to varying stages of disease, preparing them to optimize care for patients with TED.

Read moreCollapse

(CE Podcast) Curbing Demodex Blepharitis: Meet the Mitey Challenge

Friday, December 6, 2024 • Duration 48:48

Activity Description and Purpose
Demodex are ectoparasites that inhabit human hair follicles, including those on the face and eyelashes. Large infestations can cause Demodex blepharitis, a condition that has been associated with dry eye, meibomian gland dysfunction, and rosacea. Until recently, there were no US Food and Drug Administration–approved treatments for Demodex blepharitis, and off-label treatments were not reliably effective. This podcast covers the diagnosis and treatment of Demodex, including the recently approved treatment lotilaner, 0.25%.

Target Audience
This educational activity is intended for optometrists.

Learning Objectives
After completing this activity, participants will be better able to:

Review best practices in the diagnosis of Demodex blepharitis
Develop individualized treatment plans for patients with Demodex blepharitis

For more information or to view the webcast, please visit www.courses.mededicus.com

Read moreCollapse

(CE/CME Podcast) Improving Outcomes in Patients With Geographic Atrophy: Epidemiology, Pathophysiology, and Imaging

Friday, July 12, 2024 • Duration 25:25

Activity Description and Purpose

This educational activity delves into the latest clinical practices for managing geographic atrophy (GA), a severe form of dry age-related macular degeneration. Learners will gain an in-depth understanding of epidemiologic indicators, diagnostic imaging, and the pathophysiology of GA related to the complement cascade. Learners will also gain a deeper understanding of GA by reviewing a case study along with the expert presenters. Designed to enhance clinical knowledge and improve patient outcomes, this CME/CE activity offers a comprehensive approach to understanding and diagnosing GA in clinical practice. The desired results of this educational activity are for comprehensive ophthalmologists and optometrists to enhance their knowledge of the prevalence and pathophysiology of GA and new treatment options and to improve their competence in identifying and managing patients with GA.

Target Audience

This educational activity is intended for comprehensive ophthalmologists and optometrists.

Learning Objectives

After completing this activity, participants will be better able to:

Recognize epidemiologic indicators of patients at risk for geographic atrophy
Review the clinically relevant features of geographic atrophy on imaging
Describe the pathophysiology of geographic atrophy related to the complement cascade

Read moreCollapse

(CE/CME Podcast) Improving Outcomes in Patients With Geographic Atrophy: Treatment and Referral

Friday, July 12, 2024 • Duration 22:15

Activity Description and Purpose

This educational activity explores the advancements in geographic atrophy (GA) treatment options, focusing on clinical science data and real-world clinical presentations. Participants will gain insights into the latest US Food and Drug Administration–approved treatments, their mechanisms of action, clinical trial results, and patient safety considerations. Additionally, the educational activity emphasizes application in clinical practice via case examples, effective patient counseling techniques, and referral strategies to enhance patient outcomes and quality of life. This CME/CE activity is designed to enhance clinical competence and improve patient care in the management of GA. The desired results of this educational activity are for comprehensive ophthalmologists and optometrists to enhance their knowledge of the prevalence and pathophysiology of GA and new treatment options and to improve their competence in identifying and managing patients with GA.

Target Audience

This educational activity is intended for comprehensive ophthalmologists and optometrists.

Learning Objectives

After completing this activity, participants will be better able to:

Review clinical data for complement inhibitors used in the treatment of geographic atrophy
Develop appropriate treatment plans for patients with geographic atrophy
Employ appropriate counseling techniques for patients with geographic atrophy to facilitate referral

Read moreCollapse

Discussing Evaporative Dry Eye: Incorporating New Treatments Into Practice (CME/CE)

Wednesday, January 3, 2024 • Duration 24:18

Access the disclosures, evaluation, and your CME credit via:
https://courses.mededicus.com/content/discussing-evaporative-dry-eye-incorporating-new-treatments-practice-cmece-podcast

This podcast with Dr. Ken Beckman and Dr. Jaclyn Garlich delves into presentation and treatments of evaporative dry eye primarily caused by meibomian gland dysfunction (MGD). It explores the multifactorial nature of dry eye disease (DED), emphasizing the significance of MGD-driven DED, characterized by a deficient tear lipid layer. The discussion focuses on the latest treatment options, moving beyond traditional anti-inflammatory therapies to include newer topical solutions targeting evaporative loss. Real patient case studies contextualize these innovative approaches in the clinical management of DED.

After completing this activity, participants will be better able to:

Incorporate diagnostic strategies that examine meibomian gland function in routine practice
Design evidence-based treatment plans for persons with meibomian gland dysfunction–associated dry eye disease

Read moreCollapse

MedEdicus Podcasts – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

MedEdicus Podcasts – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other5

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Other5

Apple Podcasts

Spotify